N-(6-18F-fluorohexyl)-N-methylpropargylamine: a fluorine-18-labeled monoamine oxidase B inhibitor for potential use in PET studies (Q48252695)

10 February 2018

title

N-(6-18F-fluorohexyl)-N-methylpropargylamine: a fluorine-18-labeled monoamine oxidase B inhibitor for potential use in PET studies (English)

1 reference

10 February 2018

author

Jogeshwar Mukherjee

series ordinal

1

1 reference

10 February 2018

author name string

Yang ZY

series ordinal

2

1 reference

10 February 2018

Lew R

series ordinal

3

1 reference

10 February 2018

publication date

1 January 1999

1 reference

10 February 2018

Nuclear Medicine and Biology

published in

1 reference

10 February 2018

volume

26

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

111-116

1 reference

10 February 2018

123I-labeling and evaluation of Ro 43-0463, a SPET tracer for MAO-B imaging

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

The relationship of efferent projections from the area postrema to vagal motor and brain stem catecholamine-containing cell groups: an axonal transport and immunohistochemical study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

Deprenyl and levodopa and Parkinson's disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

The role of alpha-adrenergic mechanisms within the area postrema in dopamine-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

Topographic immunocytochemical mapping of monoamine oxidase-A, monoamine oxidase-B and tyrosine hydroxylase in human post mortem brain stem

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

Selective, irreversible in vivo binding of [11C]clorgyline and [11C]-L-deprenyl in mice: potential for measurement of functional monoamine oxidase activity in brain using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

Synthesis of (R)-(-)- and (S)-(+)-4-fluorodeprenyl and (R)-(-)- and (S)-(+)-[N-11C-methyl]-4-fluorodeprenyl and positron emission tomography studies in baboon brain

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

The synthesis of no-carrier-added DL-4-[18F]fluorodeprenyl via the nucleophilic aromatic substitution reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

The effect of deprenyl (selegiline) on the natural history of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

Aliphatic propargylamines: potent, selective, irreversible monoamine oxidase B inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

Effect of structural modification of alkyl N-propargylamines on the selective inhibition of monoamine oxidase B activity

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2898%2900061-4

7 January 2021

10.1016/S0969-8051(98)00061-4

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018